ZyVersa Therapeutics Forms New Scientific Advisory Board to Support Development of Inflammasome ASC Inhibitor IC 100 for Obesity with Metabolic Complications ZyVersa Therapeutics forms new obesity, metabolic and inflammatory disease Scientific Advisory Board.